ArticleCancers2021

Initial Experience of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Real-World Clinical Practice.

Hideki Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.